Thomas Stoop

Published in @TheLancet, our review on #PancreaticCancer 📎Epidemiology🌎 📎Pathogenesis🔬 📎Risk factors & surveillance🕵️ 📎Diagnostics🩺 📎Treatment💊 📎Future directions🔍 … by @ammar_asrar, @ObaAtsushi, T. Seufferlein, JW Wilmink, @BasGrootKoerkam & @MarcBesselink

#Horaest 🎓 @TFStoop #CumLaude PhD ceremony today 🙌 (best 3% thesis) “A #paradigm #shift in localized #PancreaticCancer” @DPCG_official, @UvA_Amsterdam ⏩️ dare.uva.nl/search?identif… ✅#PREOPANC4 nationwide 🇳🇱 implementation LAPC surgery ✅International, national studies on #neoadjuvant #adjuvant treatment #quality of life and #surgery in #PancreaticCancer ✅543 pages, 19 chapters (incl @TheLancet), 150 co-authors, 20 countries, 286 impact factor points; median 10+. Thank you @sparrelid🇸🇪 for the excellent discussion!

Proud to have Dr.Oba in our Division! Dive into the story below.

Bihormonal Artificial Pancreas after #Total #Pancreatectomy? ✅Protocol #PANORAMA trial published @BjsOpen @DPCG_official 🇳🇱 >> results coming up…. ⏩️ academic.oup.com/bjsopen/articl…

@CUpancreas @CUDeptSurg @RichSchulickMD @chiaro_del Thank you @RichSchulickMD. It has been an honor working for you at @CUAnschutz, inspired by your expertise, leadership, and kindness 🙏🏻.

We extend our sincerest gratitude to Dr. Schulick for his exceptional service as Chair of the @CUDeptSurg, during which he guided significant growth and innovation. His vision and dedication leave an extraordinary impact. #ImproveEveryLife @RichSchulickMD @chiaro_del

#HoraEst today for @annegehrels om #PancreaticCancer with @DPCG_official 🇳🇱 @UvA_Amsterdam ⏩️ hdl.handle.net/11245.1/0af5e1… ✅#NAPAN trial: Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: the phase I/II randomized trial ✅#PREOPANC5 trial protocol: Neoadjuvant mFOLFIRINOX, pembro, and SBRT for borderl resect pancreatic cancer: multicenter phase 1/2 single-arm trial Excellent multidisciplinary collaboration Hanneke Wilmink, Hanneke van Laarhoven an in the committe Davide Melisi 🇮🇹

#HoraEst today for @MichielFrancken @amsterdamumc @UvA_Amsterdam “Interventions for pancreatic diseases” ✅ #POINTER trial costs ✅#PICUS2 cholecystectomy for idiopathic pancreatitis, trial design ✅#PANACOTTA (obot vs open PJ chronic pancreatitis, trial design Incl committee @DeMadaria 🇪🇸 gracias Enrique🙌 dare.uva.nl/search?field1=…

The evidence would support performing diag laparoscopy prior to #NAT💊 and surgery✂️ 22% detection rate of occult metastases on🥢 in upfront resection pts in modern series with high quality imaging 🖥️ at experienced center @PanCAN @SocSurgOnc @IHPBA pmc.ncbi.nlm.nih.gov/articles/PMC10…

Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies hpbonline.org/article/S1365-…

@CUSurgOnc @CUpancreas @CUDeptSurg @ObaAtsushi Congratulations Atsushi & @chiaro_del, truly wonderful🥇!!

The Division of Surgical Oncology is thrilled to welcome Atsushi Oba, MD, PhD as Associate Professor of Surgery at the University of Colorado Anschutz Medical Campus! @CUpancreas @CUDeptSurg @ObaAtsushi #ImproveEveryLife

Staging laparoscopy 🙈 waste of time or added value!? 🗣️ 617 Surgeons / 76 countries ⏱️ Mostly performed same session laparotomy 🧐 Useful in suspicious radiology / ⬆️ CA 19.9 👉 Does not hurt + increase staging accuracy hpbonline.org/article/S1365-…

@MarcBesselink @Gio_Marchegiani @BasGrootKoerkam @IHPBA @JSHBPS @chiaro_del @Caspervaneijck @EAHPBA

In @hpbjournal, 🌎 survey on use & indications of staging laparoscopy in #PDAC (617 surgeons, 76 countries): 📎82% uses SL 📎geographic variety 📎mainly in only selected patients 📎read more about timing & diagnostic adjuncts 👉 hpbonline.org/article/S1365-… 📯more evidence⚠️

Hepatic Arterial Infusion Pump Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma 🔎PUMP-2 Trial @JCO_ASCO doi.org/10.1200/JCO-25… 👉48 pts HAIP floxuridine + CTx 👉PR: 44%; DCR: 84% 👉1-year OS: 80.0% 🧐strong signal, interesting opportunity for downstaging, 👉looking forward to the next trial

As of last Friday, I am a Professor of Surgery @karolinskainst, adjunct to my position as Senior Consultant Surgeon @KarolinskaUnsju. While this is, of course, a personal achievement, it also represents recognition of all members of the @HpbKarolinska

Endoscopic or surgical #gastroenterostomy for palliation malignant gastric outlet obstruction? 🚀Today @LancetGastroHep: #ENDURO randomised multicenter trial @DPCG_official 🇳🇱 Excellent nationwide collaboration #surgery & #gastroenterology 🙌 ⏩️ sciencedirect.com/science/articl…

Neoadjuvant FOLFIRINOX vs neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer 🔎PREOPANC-2 phs 3 @LancetOncology doi.org/10.1016/S1470-… 👉FOLFIRINOX & gemcitabine-based regimens can be used in the neoadjuvant setting

#HoraEst 🎓today @nine_degraaf @UvA_Amsterdam: “Minimally invasive versus open #pancreatic #surgery” ✅Collaboration @e_mips @DPCG_official ✅81 authors, 12 countries ✅8 chapters, incl #DIPLOMA2 trial, published in @NEJMEvidence, @LancetGastroHep, @JAMASurgery, @AnnalsofSurgery, @BJSurgery ⏩️ hdl.handle.net/11245.1/16410c… Team @Abuhilal9Abu @LuyerMisha Jony van Hilst @MarcBesselink

🆕Online today: Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable #pancreaticpancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial @BasGrootKoerkam, @MarcBesselink, Dutch Pancreatic Cancer Group thelancet.com/journals/lanon…